MOX Nanosensors to Detect Colorectal Cancer Relapses from Patient’s Blood at Three Years Follow-Up, and Gender Correlation
Colorectal cancer represents 10% of all the annual tumors diagnosed worldwide, being often not timely diagnosed, because its symptoms are typically lacking or very mild. Therefore, it is crucial to develop and validate innovative low-invasive techniques to detect it before becoming intractable. To t...
Saved in:
Main Authors: | Michele Astolfi, Giulia Zonta, Cesare Malagù, Gabriele Anania, Giorgio Rispoli |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Biosensors |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6374/15/1/56 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bufalin targets the SRC-3/c-Myc pathway in chemoresistant cells to regulate metastasis induced by chemoresistance in colorectal cancer
by: Jinbao Chen, et al.
Published: (2025-02-01) -
Sulforaphane in alternative cancer chemotherapy: From carcinogenesis suppression to drug resistance reversal
by: Seyed Mohammad Doodmani, et al.
Published: (2025-01-01) -
Volatile Organic Compounds and Carbonyls Pollution in Mexico City and an Urban Industrialized Area of Central Mexico
by: Elizabeth Vega, et al.
Published: (2022-04-01) -
Do nano-boom à paralisação: a trajetória da política brasileira de nanotecnologia
by: Noela Invernizzi, et al.
Published: (2019-01-01) -
Synthetic inhibition of SREBP2 and the mevalonate pathway blocks rhabdomyosarcoma tumor growth in vitro and in vivo and promotes chemosensitization
by: Silvia Codenotti, et al.
Published: (2025-02-01)